Pepdox
Studies
Peptides
Calculator
Interpreting Post-Discontinuation Trajectories After Semaglutide or Tirzepatide. | Pepdox
Home
/
Search
/
PMID 41873004
Interpreting Post-Discontinuation Trajectories After Semaglutide or Tirzepatide.
Diabetes, obesity & metabolism
2026
PMID: 41873004
View on PubMed
DOI: 10.1111/dom.70710
Semaglutide
Tirzepatide
Authors
Sun, Man; Zang, Dan; Chen, Jun
Keywords
antidiabetic drug
antiobesity drug
obesity therapy
type 2 diabetes
weight management